{
    "2019-12-10": [
        [
            {
                "time": "2019-01-03",
                "original_text": "Biotech ETFs Hit New Highs on Deal Activities",
                "features": {
                    "keywords": [
                        "Biotech",
                        "ETFs",
                        "New Highs",
                        "Deal Activities"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-15",
                "original_text": "Merck Stock Is On An Upswing In 2019 â€” Should You Buy This Pharma Stock?",
                "features": {
                    "keywords": [
                        "Merck",
                        "Upswing",
                        "Pharma",
                        "Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-01",
                "original_text": "Drug manufacturers have spent a record $342 billion on M&A in 2019",
                "features": {
                    "keywords": [
                        "Drug manufacturers",
                        "M&A",
                        "record",
                        "$342 billion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}